Rchr
J-GLOBAL ID:201001067266790569   Update date: Jul. 16, 2024

Nishinakagawa Takuya

ニシナカガワ タクヤ | Nishinakagawa Takuya
Affiliation and department:
Research field  (1): Immunology
Research keywords  (1): tumor immunity
Research theme for competitive and other funds  (2):
  • 2019 - 2022 マイコプラズマ由来アルギニン代謝制御蛋白質を標的とした新規がん免疫療法の開発
  • 2011 - 2015 Research of established monoclonal antibodies against tumor related molecules in a pancreatic juice
Papers (26):
  • Takuya Nishinakagawa, Mai Hazekawa, Masato Hosokawa, Daisuke Ishibashi. RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylation. Molecular Medicine Reports. 2023. 27. 3
  • Mai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, Daisuke Ishibashi. Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model. Pharmaceutics. 2022. 14. 4. 815-815
  • Mai Hazekawa, Takuya Nishinakagawa, Takeshi Mori, Miyako Yoshida, Takahiro Uchida, Daisuke Ishibashi. Preparation of siRNA-PLGA/Fabʹ-PLGA mixed micellar system with target cell-specific recognition. Scientific Reports. 2021. 11. 1
  • Tomoyo Kawakubo-Yasukochi, Ena Yano, Soi Kimura, Takuya Nishinakagawa, Akiko Mizokami, Yoshikazu Hayashi, Yuji Hatakeyama, Kenji Ohe, Atsushi Yasukochi, Seiji Nakamura, et al. Hepatic glycogenolysis is determined by maternal high-calorie diet via methylation of Pygl and it is modified by oteocalcin administration in mice. Molecular Metabolism. 2021. 54. 101360-101360
  • Takeshi Mori, Mai Hazekawa, Miyako Yoshida, Takuya Nishinakagawa, Takahiro Uchida, Daisuke Ishibashi. Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells. International Journal of Pharmaceutics. 2021. 606. 120891-120891
more...
MISC (3):
  • 西中川拓也, 細川雅人, 石橋大輔. がん細胞培養上清に含まれる細胞障害活性因子. 日本生化学会大会(Web). 2023. 96th
  • 前野史佳, 西中川拓也, 甲斐茜, 内原佑月, 細川雅人, 石橋大輔. Cytotoxic active factor in supernatants of cancer cell line cultures. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 小野菜々子, 西中川拓也, 細川雅人, 石橋大輔. Biological characteristic of tumor associated antigen 22-1-1. 日本薬学会年会要旨集(Web). 2023. 143rd
Lectures and oral presentations  (18):
  • RCAS1 increases cell morphological change in fibroblasts by reducing p38 phosphorylation
    (第81回日本癌学会学術総会 2022)
  • 腫瘍関連抗原RCAS1の生物学的機能解析
    (日本薬学会第142年会 2022)
  • Involvement of p38 signaling pathway in the RCAS1 induced cell morphological change
    (第80回日本癌学会学術総会 2021)
  • がん細胞培養上清中に含まれる細胞障害活性因子
    (日本薬学会第141年会 2021)
  • Identification of cytotoxic factor contained in tumor cell line supernatants
    (第79回日本癌学会学術総会 2020)
more...
Professional career (1):
  • 博士(薬学) (福岡大学)
Association Membership(s) (3):
日本薬学会 ,  日本がん免疫学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page